| BMD | Becker Muscular Dystrophy |
| DMD | Duchenne Muscular Dystrophy |
| aBMD | Ambulatory BMD |
| naBMD | Non-ambulatory BMD |
| Cnt | Healthy Control |
| CK | Creatine Kinase |
| LFQ | Label-Free Quantification |
| TMT | Tandem Mass Tag |
| SILAC | Stable Isotope Labeling Amino Acids by Cell Culture |
| ELISA | Enzyme-linked immunosorbent assay |
| DDA | Data dependent acquisition |
| PRM | Parallel Reaction Monitoring |
| LC-MS/MS | Liquid chromatography tandem mass spectrometry |
| VPAP | Tryptic titin peptide: VPAPVEIPVTPPTLVSGLK |
| TITIN | Titin |
| MYH2 | Myosin heavy chain 2 |
| MYH7 | Myosin heavy chain 7 |
| MYBPH | Myosin-binding protein H |
| TELT | Telethonin |
| BIN1 | Myc-box dependent interacting protein 1 |
| FLNC | Filamin C |
| GAPDH | Glyceraldehyde dehydrogenase |
| CDH13 | Cadherin 13 |
| TFA | Trifluoroacetic acid |
| ACN | Acetonitrile |
| FA | Formic acid |
| 6-MWT | 6-minute walk test |
| NSAA | NorthStar Ambulatory Assessment Score |
| MRI | Magnetic resonance imaging |
| SMA | Adult spinal muscular atrophy |
| DM1 | Myotonic dystrophy |
| FCMD | Fukuyama congenital muscular dystrophy |
| ALS | Amyotrophic lateral sclerosis |
| LGMDR1 | Limb–Girdle Muscular Dystrophy (specifically R1) |
| DCM | Dilated cardiomyopathies |
| PMO | Phosphorodiamidate Morpholino Oligomers |
| bmx | BMD mouse model |
| mdx | DMD mouse model |
| GRMD | Golden retriever muscular dystrophy model |
| PSMs | Peptide spectral matches |
| FDR | False discovery rate |